Ascendis Shares Rally Premarket as FDA Doesn't Seek New Studies

By Colin Kellaher


Shares of Ascendis Pharma AS rose sharply in premarket trading Monday after the biopharmaceutical company said the U.S. Food & Drug Administration turned away its... | May 1, 2023

Related Keywords

Colin Kellaher ,Us Food Drug Administration , ,Ascendis Pharma ,Drug Administration ,Denmark Based Ascendis ,Dow Jones ,Ascendis Pharmaas Stock Exchange ,News ,Information ,Press Release ,Y ,Colin ,Kellaher ,Hares ,F ,Ascendis ,Dharma ,Us ,Nose ,Harply ,N ,Premarket ,Trading ,Monday ,After ,The ,Iopharmaceutical ,Company ,Aid ,Wood ,Drug ,Administration ,Urned ,Way Asnd Us04351p1012 ,